Heart failure drug showdown: which treatment keeps patients out of hospital?
NCT ID NCT07376265
Summary
This study looked back at health records of 1,249 Portuguese patients with weakened heart pumping (heart failure with reduced ejection fraction). It compared how well two types of medications worked: sacubitril/valsartan (a newer combination drug) versus older standard medications (ACE inhibitors or ARBs). Researchers tracked which patients had fewer heart-related deaths, hospital visits, and healthcare costs over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.